Your browser doesn't support javascript.
loading
Resultados a corto plazo de angioplastía de rescate en pacientes con infarto agudo de miocardio con trombólisis fallida / Short-term results of rescue angioplasty in patients with acute myocardial infarction and failure of thrombolysis treatment
Palomo Villada, José Antonio; Santiago Hernández, Jaime Alfonso; González Díaz, Belinda; Astudillo Sandoval, Raúl; Flores Flores, Jesús; Montoya Silvestre, Armando; Estrada Gallegos, Joel; Bernal Ruiz, Enrique; Farell Campa, Javier.
  • Palomo Villada, José Antonio; Centro Médico Nacional Siglo XXI. Hospital de Cardiología. México, D.F.. MX
  • Santiago Hernández, Jaime Alfonso; s.af
  • González Díaz, Belinda; s.af
  • Astudillo Sandoval, Raúl; s.af
  • Flores Flores, Jesús; s.af
  • Montoya Silvestre, Armando; s.af
  • Estrada Gallegos, Joel; s.af
  • Bernal Ruiz, Enrique; s.af
  • Farell Campa, Javier; s.af
Arch. cardiol. Méx ; 75(3): 296-305, jul.-sep. 2005. tab
Article in Spanish | LILACS | ID: lil-631903
RESUMEN
El objetivo es describir nuestra experiencia, resultados clínicos y angiográficos inmediatos en pacientes con IAM sometidos a angioplastía coronaria transluminal percutánea de rescate (ACTPR). Material y

métodos:

Tipo de estudio; retrospectivo, observacional, transversal y descriptivo con seguimiento a 30 días. De enero de 2001 a julio de 2004 se realizaron 3,238 procedimientos de ACTP con aplicación de stent a pacientes con diagnóstico de cardiopatía isquémica por aterosclerosis coronaria, se seleccionó a 32 pacientes que representan el 0.98%, con edad de 47 a 79 años promedio de 63, 24 (75%) del sexo masculino, con hipertensión arterial sistémica 29 (90.6%), diabetes mellitus 18 (56.3%), hipercolesterolemia 11 (34.4%), tabaquismo 24 (75%), con antecedentes de angina inestable 9 (28.1%) y con infarto miocardio previo 2 (6.3%). La localización del IAM anterior extenso 14 (43.8%), anteroseptal en 6 (18.8%), postero-inferior en 5 (15.6%), Pl con extensión eléctrica y/o hemodinámica en VD en 4 (12.5%), lateral en 1 (3.1%). Se trombolizaron en un tiempo promedio 3.19 horas (rango 2-7) con estreptoquinasa 19 (59.4%) y con rTPA 13 (40.6%), la CPK-MB pico (U) promedio de 348 ± 240. Con Killip Kimball (KK) 1 en cinco (15.6%), II 16 (50%), III 5 (15.6%) y IV 6 (18.8%) éstos manejados con balón intraaórtico de contrapulsación.

Resultados:

Llevados a sala de hemodinamia en un tiempo de 6 a 24 h encontrando flujo TIMI 0 en 16 (50%), TIMI 1 en diez (31.2%), TIMI 2 en seis (18.8%), promedio de vasos enfermos de 1.9. Se implantó stent en 27 (84.3%). Éxito angiográfico post ACTP más stent TIMI 3 en 24 (75%). Complicaciones En 9(28.1%), en 7 (21.8%) con no reflujo y en 1 (3.1%) disección de la arteria coronaria relacionada con el IAM, 6 (18.7%) que fallecieron, en 4 (12.5%) con choque cardiogénico; 3 (9.3%) la ACTPR fue fallida.

Conclusión:

La ACTPR es un procedimiento de alto riesgo y pese a ello es una buena alternativa de tratamiento en pacientes con trombólisis fallida.
ABSTRACT
The present study is aimed at describing the short-term assessment of clinical and angiographic results in patients with acute myocardial infarction treated with rescue percutaneous transluminal coronary angioplasty (RPTCA).

Methods:

We reviewed retrospectively, from January 2001 to July 2004, the interventional procedures performed in patients with coronary heart disease. From a total of 3,258 patients we selected 32 (0.98%) with acute myocardial infarction and failure of thrombolysis treatment, which were treated with RPTCA to relief the symptoms. Average age was 63 years (range 47-79), there were 24 men (75%); hypertension in 29 (90.6%); diabetes mellitus in 18 (56.3%); currently smoking 24 (75%); dyslipidemia in 11 (34.4%); unstable angina in 9 (28.1%); previous myocardial infarction in 2 (6.3%). The area related to the infarction was anterior and lateral in 14 (43.8%), anteroseptal in 6 (18.8%), postero-inferior in 5 (15.6%) with electric and hemodynamic involvement in 4 (12.5%), lateral in 1(3.1 %). Thrombolysis treatment was delivered in 3.19 hours (range 2-7 hours) with streptokinasein 19 (59.4%) and rTPA in 13 (40.6%). The evaluated serum marker was CPK-MB with the highest level of 348 ± 240 U/L. Killip Kimball (KK) class was established as follows KKI in 5 (15.6%), II in 16 (50%), III in 5 (15.6%), and IV in 6 (18.8%). Patients with cardiogenic shock were treated with intra-aortic balloon counterpulsation.

Results:

Time between symptoms and arrival to the cath lab was 11 hours (range 6-24 hours). TIMI flow was TIMI 0 in 16(50%). TIMI 1 in 10 (31.2%), TIMI 2 in 6 (18.8%). The number of vessels with a significant lesion was 1.9 (range 1-4). Stents were placed in 27 (84.3%) patients. Angiographic success post-angioplasty was achieved in 24 (75%); there were 9 complications (28.1%), no reflow in 7 (21.8%), coronary dissection in 1 (3.1%). Six patients died (18.7%) and 4 of them (12.5%) were in cardiogenic shock.

Conclusion:

RPT-CA is a high-risk procedure, being an acceptable treatment option for patients with thrombolysis failure.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Streptokinase / Angioplasty, Balloon, Coronary / Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents / Myocardial Infarction Type of study: Etiology study / Evaluation studies / Observational study / Risk factors Limits: Aged / Female / Humans / Male Language: Spanish Journal: Arch. cardiol. Méx Journal subject: Cardiology Year: 2005 Type: Article Affiliation country: Mexico Institution/Affiliation country: Centro Médico Nacional Siglo XXI/MX

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Streptokinase / Angioplasty, Balloon, Coronary / Thrombolytic Therapy / Tissue Plasminogen Activator / Fibrinolytic Agents / Myocardial Infarction Type of study: Etiology study / Evaluation studies / Observational study / Risk factors Limits: Aged / Female / Humans / Male Language: Spanish Journal: Arch. cardiol. Méx Journal subject: Cardiology Year: 2005 Type: Article Affiliation country: Mexico Institution/Affiliation country: Centro Médico Nacional Siglo XXI/MX